Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Commercial Physical And Biological Research Ireland
Nasdaq: AMRN
Amarin Corp. Plc is a clinical-stage biopharmaceutical company. It focuses on improving the treatment of cardiovascular disease, including hypertriglyceridemia. Amarin also focusing on AMR101, a prescription-grade omega-3 fatty acid. The firm has completed two pivotal Phase 3 studies of AMR101, which include Marine and Anchor under the Special Protocol Assessment agreements with the U.S. Food and Drug Administration. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Similar to: Medivir AB, Exelixis, Inc., Advanced Cell Technology, Inc.
Louisville, KY, US
Kindred Healthcare, Inc., a top-125 private employer in the United States, is a FORTUNE 500 healthcare services company based in Louisville,… Learn more →

Marlborough, MA, US
Advanced Cell Technology, Inc. is a biotechnology company that develops cellular therapies for the treatment of rare and common diseases… Learn more →

South San Francisco, CA, US
Exelixis, Inc. develops human therapeutics by innovating therapies for cancer and other serious diseases to various pharmaceutical… Learn more →

Stockholm, SE
Medivir is a research based pharmaceutical company focused on infectious diseases and Nordic market presences were we market 15 products… Learn more →